New Light-Based imaging could speed up lung cancer diagnosis

NCT ID NCT05171478

First seen Jan 08, 2026 · Last updated Jun 22, 2026 · Updated 24 times

Summary

This study is testing a new imaging technique called full-field optical coherence tomography (FFOCT) to examine small lung biopsy samples taken during bronchoscopy. Researchers want to see if FFOCT can provide results that match standard lab analysis, potentially allowing faster diagnosis of lung cancer and sarcoidosis. The study will enroll 20 adults already scheduled for a bronchoscopy as part of their routine care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Johns Hopkins Hospital

    RECRUITING

    Baltimore, Maryland, 21287, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Full-field optical coherence tomography (FFOCT) imaging

What this could lead to

If successful, FFOCT could provide faster, more accurate on-the-spot analysis of lung biopsies, potentially reducing wait times for diagnosis.

What could go wrong

This is a small early study with only 20 participants, and it is testing a new imaging tool against standard methods. It may not prove reliable enough for routine use.

Conditions

The condition(s) this trial relates to.

lung neoplasm sarcoidosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.